AI-based DR severity screening tool shows comparable results to human reading centers

LAS VEGAS — Ocula360, an AI-based tool for diabetic retinopathy lesion detection, showed efficacy in detecting DR across multiple levels of severity, according to a speaker at Clinical Trials at the Summit. While several automated DR assessment tools have been FDA approved, there are limitations in screening for disease severity, SriniVas R. Sadda, MD, of Doheny Eye Institute, said.

Raccontata dahealio.com